Fabtech Technologies Cleanrooms Limited (BSE SME)
Jan 3, 2025 - Jan 7, 2025
| Price | ₹80 - ₹85 |
| Premium | ₹105 |
|---|---|
| Lot size | 1600 |
| Allotment | Jan 8, 2025 |
| Listing | Jan 10, 2025 |
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
| Retail | 1 | 1600 | 136000 | 679 |
| HNI | 2 | 3200 | 272000 | 291 |
Last updated on 07-Jan-2025 18:59:02
| Category | Offered | Applied | Times |
|---|---|---|---|
| QIBs | 619200 | 139008000 | 224.5 |
| HNIs | 465600 | 691816000 | 1485.86 |
| Retail | 1086400 | 776835200 | 715.05 |
| Total | 2171200 | 1607659200 | 740.45 |
| Total Applications: 781106 | |||
| QIB Interest Cost Per Share (7 Days) | |||||
|---|---|---|---|---|---|
| @7% ₹25.6 | @8% ₹29.3 | @9% ₹32.9 | @10% ₹36.6 | @11% ₹40.3 | @12% ₹43.9 |
| HNI Interest Cost Per Share (7 Days) | |||||
|---|---|---|---|---|---|
| @7% ₹169.6 | @8% ₹193.8 | @9% ₹218 | @10% ₹242.2 | @11% ₹266.4 | @12% ₹290.7 |
Fabtech Technologies IPO Details
| Issue Size | 32,64,000 shares (aggregating up to ₹27.74 Cr) |
| Fresh Issue | 32,64,000 shares (aggregating up to ₹ 27.74 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE SME |
| Share Holding Pre Issue | 90,55,362 shares |
| Share Holding Post Issue | 1,23,19,362 shares |
| Market Maker Portion | 1,64,800 shares |
| Market Maker | Rikhav Securities Limited |
Fabtech Technologies IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50% of the Net Issue |
| Retail Shares Offered | Not less than 35% of the Net Issue |
| NII (HNI) Shares Offered | Not less than 15% of the Net Issue |
Key Performance Indicator
| KPI | Sep-24 | Mar-24 | Mar-23 |
|---|---|---|---|
| ROE | 9.53% | 11.96% | 19.27% |
| ROCE | 11.85% | 15.83% | 26.18% |
| RONW | 9.53% | 11.95% | 19.27% |
| D/E | 0.05 | 0.11 | 0.13 |
| EPS (basic) | 6 | 6.92 | 9.53 |
| P/E Pre IPO | 13.31 | ||
| P/E Post IPO | 9.69 |
Company Financials In Lakhs
| Period Ended | Sep-24 | Mar-24 | Mar-23 | Mar-22 |
|---|---|---|---|---|
| Assets | 9,439 | 8,912 | 8,058 | 8,188 |
| Revenue | 6,223 | 9,799 | 12,510 | 11,395 |
| Profit After Tax | 540 | 578 | 796 | 360 |
| Net Worth | 6,188 | 5,145 | 4,530 | 3,735 |
| Reserves and Surplus | 5,300 | 4,887 | 4,275 | 3,479 |
| Total Borrowing | 320 | 575 | 566 | 850 |
About Company
Fabtech Technologies Cleanrooms Limited, incorporated in 2015, specializes in manufacturing pre-engineered and pre-fabricated modular panels and doors for cleanrooms used in the pharmaceutical, healthcare, and biotech industries. The company serves as an end-to-end supplier of cleanroom products and technology, offering a comprehensive product range that includes cleanroom panels, view panels, doors, ceiling panels, covings, HVAC systems, and electrification works, all tailored to specific plant designs and requirements. With extensive expertise in designing, manufacturing, and installing cleanrooms, the company also provides essential after-sales support. Its primary manufacturing facility is located in Umbergaon, Valsad, Gujarat, covering 70,000 sq. ft., and is equipped with advanced machinery for cleanroom partition production. Through its subsidiary, Altair Partition Systems LLP, the company also manufactures economical-grade modular panels at a leased 25,000 sq. ft. facility in Murbad, Thane. As of November 30, 2024, Fabtech Technologies Cleanrooms Limited employs 117 permanent staff, reflecting its operational scale and commitment to quality and service.
Vivro Financial Services Private Limited
Diverse Domain Expertise: Strong capabilities in cleanroom design, manufacturing, and installation across multiple sectors.
Inorganic Growth Strategy: Focus on strategic integrations and acquisitions to drive business expansion.
Group Support: Backed by a larger group company, providing additional resources and business synergies.
Negative Cash Flows: The company has experienced negative cash flows in prior periods, which could impact financial stability.
Contingent Liabilities: Outstanding contingent liabilities may negatively affect the company’s financial condition if they materialize.
Sector Dependence: Heavy reliance on the pharmaceutical, healthcare, and biotech sectors exposes the company to risks from adverse developments or capital expenditure fluctuations in these industries.
Maashitla Securities Private Limited
Phone: +91-11-45121795-96
Email: ipo@maashitla.com
Website: https://maashitla.com/allotment-status/public-issues